Vasculogenic mimicry of human ovarian cancer cells: Role of CD147

International Journal of Oncology

Volumn 35, Issue 6, 2009, Pages 1423-1428

  Millimaggi, Danilo ^a   Mari, Marianna ^a   D'Ascenzo, Sandra ^a   Giusti, Ilaria ^a   Pavan, Antonio ^b   Dolo, Vincenza ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Angiogenesis; CD147; Ovarian cancer; Vasculogenic mimicry

Indexed keywords

CD147 ANTIGEN; BSG PROTEIN, HUMAN;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL FUNCTION; CELL INVASION; CONTROLLED STUDY; ENZYME ACTIVITY; HISTOGENESIS; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL; PROTEIN FUNCTION; VASCULOGENIC MIMICRY; FEMALE; METABOLISM; OVARY TUMOR; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; WESTERN BLOTTING;

ANTIGENS, CD147; BLOTTING, WESTERN; CELL LINE, TUMOR; FEMALE; HUMANS; NEOPLASM INVASIVENESS; OVARIAN NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 73949092391     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000460     Document Type: Article

References (33)

1. Maniotis AJFR, Hess A, Seftor EA, et al: Vascular channel formation by human melanoma cells in vivo and in vitro: vasculagenic mimicry. Am J Pathol 155: 739-752, 1999.
2. Fukumura D, Xavier R, Sugiura T, et al: Tumor indution of VEGF promotor activity in stromal cells. Cell 94: 715-725, 1998.
3. Hendrix MJC, Seftor EA, Hess AR and Seftor REB: Vasculogenic mimicry and tumor-cell plasticity: lesson from melanoma. Nat Rev 3: 411-421, 2003.
4. Seftor EA, Meltzer PS, Kirschmann DA, et al: Molecular determinants of human uveal melanoma invasion and metastasis. Clin Exp Metastasis 19: 233-246, 2002.
5. Folberg R, Hendrix MJC and Maniotis AJ: Vasculogenic mimicry and tumor angiogenesis. Am J Pathol 156: 361-381, 2000.
6. Folberg R, Rummelt V, Parys-Van Ginderdeuren R, Hwang T, Woolson RF, Pe'er J and Gruman LM: The prognostic value of tumor blood vessels morphology in primary uveal melanoma. Ophthalmology 100: 1389-1398, 1993.
7. Makitie T, Summanen P, Tarkkanen A and Kivela T: Microvascular loops and networks as prognostic indicators in choroidal and ciliary body melanomas. J Natl Cancer Inst 91: 359-367, 1999.
8. Sakamoto T, Sakamoto M, Yoshikawa H, Hata Y, Ishibashi T, Ohnishi Y and Inomata H: Histologic findings and prognosis of uveal malignant melanoma in Japanese patients. Am J Ophthalmol 121: 273-283, 1996.
9. Seregard S, Spangberg B, Juul C and Oskarsson M: Prognostic accuracy of the mean of the largest nucleoli, vascular patterns, and PC-10 in posterior uveal melanoma. Ophthalmology 105: 485-491, 1999.
10. Thies A, Mangold U, Moll I and Shumacher U: PAS-positive loops and networks as a prognostic indicator in cutaneous malignant melanoma. J Pathol 195: 337-342, 2001.
11. Warso MA, Maniotis AJ, Chen X, et al: Prognostic significance of periodic acid-Schiff-positive patterns in primary cutaneous melanoma. Clin Cancer Res 7: 473-477, 2001.
12. Rummelt V, Mehaffey MG, Campbell RJ, et al: Micro-circulation architecture of metastases from primary ciliary body and choroidal melanomas: Am J Ophthalmol 126: 303-305, 1998.
13. Folberg RMA: Vasculogenic mimicry. APMIS 112: 508-525, 2004.
14. Seftor RESE, Koshikawa N, Meltzer PS, Gardner LM, Bilban M, Stetler-Stevenson WG, Quaranta V and Hendrix MJ: Cooperative interactios of laminin 5γ2 chain, matrixmetalloproteinase-2, and membrane type-1-matrix/metalloproteinase are required for mimicry of embrionic vasculogenesis by aggressive melanoma. Cancer Res 61: 6322-6337, 2001.
15. Seftor RESE, Kirshmann DA and Hendrix MX: Targeting the tumor microenvironment with chemically modified tetracylines: inibition of laminin 5γ2 chain promigratory fragments and vasculogenic mimicry. Mol Cancer Ther 1: 1173-1179, 2002.
16. Biswas C, Zhang Y, De Castro R, Guo H, Nakamura T, Kataoka H and Nabeshima K: The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res 55: 434-439, 1995.
17. Ellis SM, Nabeshima K and Biswas C: Monoclonal antibody preparation and purification of a tumor cell collagenase stimulatory factor. Cancer Res 49: 3385-3391, 1989.
18. Plette M, Gilles C, Marchand V, et al: Tumor collagenase stimulatory factor (TCSF) expression and localization in human lung and breast cancer. J Histochem Cytochem 45: 703-709, 1997.
19. Caudroy S, Polette M, Tournier JM, et al: Expression of the extracellular matrix metalloproteinases inducer (EMMPRIN) and the matrix metalloproteinase-2 in bronchopulmonary and breast lesion. J Histochem Cytochem 47: 1575-1580, 1999.
20. Bordator LC, Li X, Toole B, et al: Expression of EMMPRIN by oral squamous cell carcinoma. Int J Cancer 85: 347-352, 2000.
21. Kanekura T, Chen X and Kanzaki T: Basigin (CD147) is expressed on melanoma cells and induces tumor cell invasion by stimulating production of matrix metalloproteinases by fibroblasts. In J Cancer 99: 520-528, 2002.
22. Sameshima T, Nabeshima K, Toole BP, et al: Expression of EMMPRIN (CD147), a cell surface inducer of matrix metalloproteinases, in normal human brain and gliomas. Int J Cancer 88: 21-27, 2000.
23. Nabeshima K, Suzumiya J, Nagano M, et al: EMMPRIN, a cell surface inducer matrix metalloproteinases (MMPs), is expressed in T-cell lynphomas. J Pathol 202: 341-351, 2004.
24. Thorns C, Feller AC and Merz H: EMMPRIN (CD147) is expressed in Hodgkin's lymphoma and anaplastic large cell lymphoma. An immunohistochemical study of 60 cases. Anticancer Res 22: 1983-1986, 2002.
25. Yan L, Shahied L, Tang Y, Kesavan P and Nakada MT: Tumorhost interactions. Preclinica 2: 3-8, 2004.
26. Tang Y, Nakada MT, Kesavan P, et al: Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial growth factor and matrix metalloproteinases: Cancer Res 65: 3193-3199, 2005.
27. Dolo V, Ginestra A, Violini S, et al: Ultrastructural and phenotipic characterization of CABA I, a new human ovarian cancer cell line. Oncol Res 9: 129-138, 1997.
28. Zucker S, Hymowitz M, Rollo EE, et al: Tumorigenic potential of extracellular matrix metalloproteinasen inducer. Am J Pathol 158: 1921-1928, 2001.
29. Lehti K, Valtanen H, Wickstrom S, et al: Regulation of Membrane-type-1 Matrix Metalloproteinase activity by its cytoplasmic domain. J Biol Chem 275: 15006-15013, 2000.
30. Basu G, Liang WS, Stephan AD, et al: A novel role for cyclooxigenase-2 in regulating vascular channel formation by human breast cancer cells. Breast Cancer Res 8: R69, 2006.
31. Taraboletti G, Roberts D, Liotta LA and Giavanazzi R: Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor. J Cell Biol 111: 765-772, 1990.
32. Carmeliet P: Mechanisms of angiogenesis and arteriogenesis. Nat Med 6: 389-395, 2000.
33. Sood AKKM, Coffin JE, Yang M, Seftor EA, Gruman LM, Gershenson DM and Hendrix MJ: Functional role of matrix metalloproteinases in ovarian tumor cell plasticity. Am J Obstet Gynecol 190: 899-909, 2004.